1. Defining IL‐6 levels in healthy individuals: A meta‐analysis
   Elias A. Said et al, 2021, Journal of Medical Virology CrossRef
2. NURR1 Alterations in Perinatal Stress: A First Step towards Late-Onset Diseases? A Narrative Review
   Laura Bordoni et al, 2020, Biomedicines CrossRef
3. The role of NURR1 in metabolic abnormalities of Parkinson’s disease
   Murad Al-Nusaif et al, 2022, Molecular Neurodegeneration CrossRef
4. Inflammasomes and type 2 diabetes: An updated systematic review
   Zahra Sepehri et al, 2017, Immunology Letters CrossRef
5. Modulation of microglia in the retina: new insights into diabetic retinopathy
   Ana I. Arroba et al, 2017, Acta Diabetologica CrossRef
6. Altered Expression Levels of MicroRNA-132 and Nurr1 in Peripheral Blood of Parkinson’s Disease: Potential Disease Biomarkers
   Zhaofei Yang et al, 2019, ACS Chemical Neuroscience CrossRef
7. NR4A2 alleviates cardiomyocyte loss and myocardial injury in rats by transcriptionally suppressing CCR5 and inducing M2 polarization of macrophages
   Huangtai Miao et al, 2022, Microvascular Research CrossRef
8. Dapagliflozin diminishes memory and cognition impairment in Streptozotocin induced diabetes through its effect on Wnt/β-Catenin and CREB pathway
   Hala El-Safty et al, 2022, Brain Research Bulletin CrossRef
9. The Critical Role of Nurr1 as a Mediator and Therapeutic Target in Alzheimer’s Disease-related Pathogenesis
   Seong Gak Jeon et al, 2020, Aging and disease CrossRef
10. Dysfunctional Nurr1 promotes high glucose-induced Müller cell activation by up-regulating the NF-κB/NLRP3 inflammasome axis
    Wendie Li et al, 2020, Neuropeptides CrossRef
11. SEVELAMER CARBONATE MODULATES THE NLRP3 AND NLRP6 INFLAMMASOME EXPRESSION IN PATIENTS WITH DIABETIC NEPHROPATHY
    Grațiela Grădișteanu Pîrcălăbioru et al, 2021, Romanian Archives of Microbiology and Immunology CrossRef